No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Rituximab Study Shows Promise for Managing AIBD
A study published in Medicina, on 4 February 2024, concluded that Rituximab represents an “efficacious and well-tolerated therapeutic option” for the management of Autoimmune Bullous Diseases (AIBD) and warrants consideration in cases of refractory AIBD.